CN1626536A - 一种通过结晶作用纯化莫西菌素的方法 - Google Patents
一种通过结晶作用纯化莫西菌素的方法 Download PDFInfo
- Publication number
- CN1626536A CN1626536A CNA2004100684407A CN200410068440A CN1626536A CN 1626536 A CN1626536 A CN 1626536A CN A2004100684407 A CNA2004100684407 A CN A2004100684407A CN 200410068440 A CN200410068440 A CN 200410068440A CN 1626536 A CN1626536 A CN 1626536A
- Authority
- CN
- China
- Prior art keywords
- moxidectin
- solution
- solvent
- mch
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
使用的MTM固体(克) | 使用的MCH(克) | 使用的MTM的初始纯度 | MCH蒸馏后的TS浓度% | 使用的溶剂 | 溶剂与MCH的重量比 | 结晶温度℃ | MIM纯度%(分离后)* |
5 | 7.7 | 92.6% | 39.0% | 正-己烷 | 3∶1 | 室温(RT) | 94.0% |
5 | 7.5 | 93.1% | 40.0% | 正-己烷 | 3∶1 | (RT) | 96.3% |
5 | 7.5 | 93.1% | 40.0% | 正-己烷 | 4∶1 | (RT) | 94.2% |
5 | 7.5 | 93.1% | 40.0% | 正-己烷 | 5∶1 | (RT) | 94.5% |
16.2 | 24.28 | 93.8% | 40.0% | 正-庚烷 | 3∶1 | 10℃ | 96.1% |
19.8 | 29.73 | 93.8% | 40.0% | 正-庚烷 | 3∶1 | 25℃ | 95.0% |
9.9 | 14.91 | 93.0% | 40.0% | 正-庚烷 | 3∶1 | 25℃ | 95.6% |
Claims (34)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49331703P | 2003-08-07 | 2003-08-07 | |
US60/493317 | 2003-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1626536A true CN1626536A (zh) | 2005-06-15 |
CN100439375C CN100439375C (zh) | 2008-12-03 |
Family
ID=33552111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100684407A Active CN100439375C (zh) | 2003-08-07 | 2004-08-06 | 一种通过结晶作用纯化莫西菌素的方法 |
Country Status (12)
Country | Link |
---|---|
US (2) | US7348417B2 (zh) |
EP (1) | EP1505069B1 (zh) |
JP (1) | JP4653979B2 (zh) |
KR (1) | KR101123018B1 (zh) |
CN (1) | CN100439375C (zh) |
CY (1) | CY1113198T1 (zh) |
DK (1) | DK1505069T3 (zh) |
ES (1) | ES2387390T3 (zh) |
PL (1) | PL1505069T3 (zh) |
PT (1) | PT1505069E (zh) |
SI (1) | SI1505069T1 (zh) |
TW (1) | TWI343254B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601735A (zh) * | 2013-11-08 | 2014-02-26 | 大连九信生物化工科技有限公司 | 一种提纯莫西克汀的方法 |
CN104053660A (zh) * | 2011-12-02 | 2014-09-17 | 梅里亚有限公司 | 长效的可注射的莫昔克丁配制剂和新的莫昔克丁晶型 |
CN105001232A (zh) * | 2015-07-08 | 2015-10-28 | 安徽省皖北药业股份有限公司 | 一种莫昔克丁的提纯方法 |
CN105646521A (zh) * | 2016-03-28 | 2016-06-08 | 河北圣雪大成制药有限责任公司 | 一种莫西克汀的结晶方法 |
CN107383053A (zh) * | 2017-07-25 | 2017-11-24 | 宁夏泰瑞制药股份有限公司 | 一种莫西菌素粗品的纯化方法 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0922709B8 (pt) | 2008-12-04 | 2017-03-14 | Merial Ltd | derivados diméricos de avermectina e milbemicina |
MX2012006921A (es) | 2009-12-17 | 2012-07-10 | Merial Ltd | Composiciones que comprenden compuestos de lactona macrociclica y espirodioxepinoindoles. |
EP2983712B1 (en) | 2013-04-12 | 2020-11-25 | Zoetis Services LLC | Composition of macrocyclic lactones, levamisole, an amino sugar and an additional antiparasitic agent |
KR101484481B1 (ko) * | 2014-08-07 | 2015-01-20 | 주식회사 다림바이오텍 | Pde-5 저해제를 포함하는 설하분무제의 제조방법 및 이에 의하여 제조된 설하분무용 조성물 |
KR102412089B1 (ko) * | 2021-09-13 | 2022-06-22 | 주식회사 세라수 | Dmts의 정제방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5317030A (en) * | 1984-06-05 | 1994-05-31 | American Cyanamid Company | Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents |
US5106994A (en) * | 1984-06-05 | 1992-04-21 | American Cyanamid Company | Agents and method of production thereof |
US5198464A (en) * | 1984-06-05 | 1993-03-30 | American Cyanamid Company | Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents |
US5169956A (en) * | 1984-06-05 | 1992-12-08 | American Cyanamid Company | Macrolide antibiotic compounds |
CA1296329C (en) * | 1986-06-06 | 1992-02-25 | Derek R. Sutherland | Macrolide compounds |
US4916154A (en) * | 1986-09-12 | 1990-04-10 | American Cyanamid Company | 23-Imino derivatives of LL-F28249 compounds |
US4988824A (en) * | 1989-09-11 | 1991-01-29 | Maulding Donald R | Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds |
US5478951A (en) * | 1994-06-22 | 1995-12-26 | American Cyanamid Company | Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds |
-
2004
- 2004-07-20 US US10/894,965 patent/US7348417B2/en not_active Expired - Fee Related
- 2004-07-30 PL PL04254592T patent/PL1505069T3/pl unknown
- 2004-07-30 ES ES04254592T patent/ES2387390T3/es active Active
- 2004-07-30 PT PT04254592T patent/PT1505069E/pt unknown
- 2004-07-30 SI SI200431894T patent/SI1505069T1/sl unknown
- 2004-07-30 EP EP04254592A patent/EP1505069B1/en active Active
- 2004-07-30 DK DK04254592.1T patent/DK1505069T3/da active
- 2004-08-04 TW TW093123351A patent/TWI343254B/zh not_active IP Right Cessation
- 2004-08-05 JP JP2004229533A patent/JP4653979B2/ja not_active Expired - Fee Related
- 2004-08-06 KR KR1020040062045A patent/KR101123018B1/ko not_active IP Right Cessation
- 2004-08-06 CN CNB2004100684407A patent/CN100439375C/zh active Active
-
2008
- 2008-01-29 US US12/021,429 patent/US7645863B2/en not_active Expired - Fee Related
-
2012
- 2012-08-06 CY CY20121100701T patent/CY1113198T1/el unknown
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104053660A (zh) * | 2011-12-02 | 2014-09-17 | 梅里亚有限公司 | 长效的可注射的莫昔克丁配制剂和新的莫昔克丁晶型 |
CN105232529A (zh) * | 2011-12-02 | 2016-01-13 | 梅里亚有限公司 | 长效的可注射的莫昔克丁配制剂和新的莫昔克丁晶型 |
CN104053660B (zh) * | 2011-12-02 | 2016-12-28 | 梅里亚有限公司 | 长效的可注射的莫昔克丁配制剂和新的莫昔克丁晶型 |
CN105232529B (zh) * | 2011-12-02 | 2018-11-23 | 梅里亚有限公司 | 长效的可注射的莫昔克丁配制剂和莫昔克丁晶型 |
CN103601735A (zh) * | 2013-11-08 | 2014-02-26 | 大连九信生物化工科技有限公司 | 一种提纯莫西克汀的方法 |
CN103601735B (zh) * | 2013-11-08 | 2015-12-09 | 大连九信生物化工科技有限公司 | 一种提纯莫西克汀的方法 |
CN105001232A (zh) * | 2015-07-08 | 2015-10-28 | 安徽省皖北药业股份有限公司 | 一种莫昔克丁的提纯方法 |
CN105646521A (zh) * | 2016-03-28 | 2016-06-08 | 河北圣雪大成制药有限责任公司 | 一种莫西克汀的结晶方法 |
CN107383053A (zh) * | 2017-07-25 | 2017-11-24 | 宁夏泰瑞制药股份有限公司 | 一种莫西菌素粗品的纯化方法 |
CN107383053B (zh) * | 2017-07-25 | 2019-11-05 | 宁夏泰瑞制药股份有限公司 | 一种莫西菌素粗品的纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
PT1505069E (pt) | 2012-08-07 |
JP2005053916A (ja) | 2005-03-03 |
US7645863B2 (en) | 2010-01-12 |
CN100439375C (zh) | 2008-12-03 |
DK1505069T3 (da) | 2012-07-23 |
EP1505069A1 (en) | 2005-02-09 |
EP1505069B1 (en) | 2012-07-04 |
US20080119543A1 (en) | 2008-05-22 |
US7348417B2 (en) | 2008-03-25 |
TWI343254B (en) | 2011-06-11 |
CY1113198T1 (el) | 2016-04-13 |
KR101123018B1 (ko) | 2012-03-15 |
JP4653979B2 (ja) | 2011-03-16 |
US20050033041A1 (en) | 2005-02-10 |
PL1505069T3 (pl) | 2012-12-31 |
SI1505069T1 (sl) | 2012-08-31 |
ES2387390T3 (es) | 2012-09-21 |
TW200509903A (en) | 2005-03-16 |
KR20050016205A (ko) | 2005-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7645863B2 (en) | Method of purifying moxidectin through crystallization | |
DE60122341T2 (de) | 9-substituierte minocyclin verbindungen | |
DE69918275T2 (de) | Flüssige polymerlosung zur kontrollierten freisetzung von bioaktiven substanzen | |
CN1462186A (zh) | 稳定的氨基酸固体剂型和它们的制备方法 | |
CN1568999A (zh) | 稳定的医药用河豚毒素冷冻干燥制剂 | |
KR101330063B1 (ko) | 니코우사미드 화합물의 5가지 결정형, 이의 제조방법, 약물 조합물 및 용도 | |
CH647244A5 (de) | Analoga von lincomycin und clindamycin. | |
HU203189B (en) | Stabilized macrolit-containing insecticidal, acaricidal and nematocidal compositions and process for producing pharmaceutical compositions comprising stabilized macrolides | |
EP1882476B1 (de) | Herstellung von antimikrobiellen Formulierungen unter Verwendung von 7-Oxa-2-thia 1,5-diazabicyclo[3.3.1]nonan-2,2-dion | |
DE4112464A1 (de) | Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial | |
CN113121383A (zh) | 阿福拉纳和氟雷拉纳合成砌块的有关物质及其合成方法 | |
CN1496270A (zh) | 眼科中局部使用的以大环内酯类物质为基础的药物组合物 | |
AT403162B (de) | Neue kristallform von morphin-6-glucuronid | |
CN106866533B (zh) | 吡唑醚菌酯晶型及制备方法 | |
CN1163485C (zh) | 氨氯地平系列盐及其制备方法和用途 | |
DE69627209T2 (de) | Lyophilisiertes thioxanthenon-antitumormedikament | |
CN107746423B (zh) | 麦角甾-7,22-二烯-3-酮肟及其制备方法和在制备抗菌药物中的应用 | |
EP4165016A1 (en) | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof | |
CN103301468A (zh) | 高含量的木犀草素组合物 | |
CA3186696A1 (en) | Polymorphs of 5-aza-4'-thio-2-deoxycytidine | |
CN1210040C (zh) | 防治动物皮癣菌病和螨虫病联合缓释剂的制备方法 | |
CN117643572A (zh) | 一种氟雷拉纳滴剂及其制备方法和应用 | |
RU2186777C1 (ru) | 7-ацетокси-3-(n-бромфенил)-иминометилхромон, обладающий антибактериальной активностью | |
CN1660115A (zh) | 一步合成头孢硫脒无菌粉的方法 | |
CN1789273A (zh) | 一种阿奇霉素的可溶性盐及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: PAHE CO., LTD. Free format text: FORMER OWNER: WYETH LLC Effective date: 20130618 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: WYETH LLC Free format text: FORMER NAME: WYETH CORP. Owner name: SOTEN W CO., LTD. Free format text: FORMER NAME: PAHE CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: New jersey, USA Patentee after: WYETH LLC Address before: New jersey, USA Patentee before: WYETH |
|
CP03 | Change of name, title or address |
Address after: New jersey, USA Patentee after: Zoetis Services LLC Address before: American New York Patentee before: Pach LLC |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130618 Address after: American New York Patentee after: Pach LLC Address before: New jersey, USA Patentee before: Wyeth LLC |
|
ASS | Succession or assignment of patent right |
Owner name: SHUOTENG SERVICE LLC Free format text: FORMER OWNER: SOTEN W CO., LTD. Effective date: 20150807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150807 Address after: New jersey, USA Patentee after: Zoetis Services LLC Address before: New jersey, USA Patentee before: Zoetis Services LLC |